Visceral Disease in Castration-Resistant Prostate Cancer

European Urology- Netherlands

doi 10.1016/j.eururo.2013.10.055

Full Text

Abstract

Available in

Categories

Urology

Date

Authors

Publisher

Elsevier BV

Related search

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
2019English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Exploratory Analysis of the Visceral Disease Subgroup in a Phase III Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2013English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Effect of Dutasteride on Castration‑resistant Prostate Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Molecular Mechanisms of Castration-Resistant Prostate Cancer Progression

Future Oncology
MedicineCancer ResearchOncology
2009English

ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy